US EditionMasimo sues US Customs over Apple Watch blood oxygen return
Masimo alleges the U.S. Customs and Border Protection reversed its prior ban without notice, allowing Apple to re-enable blood oxygen monitoring, which Masimo claims infringes its patents and harms competition.
- Masimo, a medical technology company, sued U.S. Customs and Border Protection over its decision to allow Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the two companies.
- Masimo claims that Customs improperly reversed its previous decision without notifying Masimo, allowing Apple to reintroduce blood-oxygen reading to its watches.
- Masimo argues that Customs' decision effectively nullified an International Trade Commission order against Apple, and the company is seeking a court order to block the decision and reinstate the original ruling.
31 Articles
31 Articles
Masimo Sues US Customs Over Approval of Apple Watch Imports
Masimo sues US Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.
Masimo files lawsuit over Apple's 'redesigned' blood oxygen monitoring feature
Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released its redesigned blood oxygen monitoring feature. This is just the latest update in the lengthy legal saga between Masimo and Apple, which started when the former sued the iPhonemaker in 2021, accusing it of infringing on several of its light-based blo…
Coverage Details
Bias Distribution
- 46% of the sources lean Left, 46% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
